#drug pricing

After years of thundering against drugmakers, legislators have now focused on regulating the deal-makers known as pharmacy benefit managers.

An unusual alliance among senators emerged in the push to allow for the importation of drugs from Canada and the United Kingdom.

The court sided with the hospitals, which challenged a $1.6 billion Trump-era cut to 340B Medicare reimbursements.

Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

Lower doses of some cancer drugs might be just as effective and less risky than what is currently prescribed by doctors.

The report found U.S. cancer patients spent $5.6 billion in out-of-pocket costs for cancer treatment in 2018.

Speciality drug prices are so costly that many patients skip or ration them.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

Oncologist wins Senate backing by a vote of 72 to 18.

People who paid more money out-of-pocket filled fewer prescriptions and had shorter overall survival.

A look at what the law says about buying prescription drugs from Canada.

Insurance companies can no longer implement harmful co-pay accumulator policies.

10 strategies to keep down the costs of cancer care

Specialty-tier drugs for multiple sclerosis, cancer and other conditions account for more than 20 percent of total spending in Part D plans.

He believes that America has the resources to make drugs and treatment more affordable for everyone.